Nigeria’s HIV Cases Decline in Four Months

Nigeria recorded a steady decline in reported HIV cases between January and April 2026, amid rising uptake of Lenacapavir, a newly introduced twice-yearly HIV prevention injection across several states.

Data from the National Data Repository showed that confirmed cases dropped consistently over the four-month period, from 8,494 in January to 7,893 in February, 7,814 in March, and 6,458 in April.

The Federal Government has begun rolling out Lenacapavir, a long-acting injectable used for both HIV prevention and treatment support among high-risk populations. The drug is administered once every six months and is being introduced as part of national HIV control efforts.

The initial implementation phase covers eight states: Akwa Ibom, Anambra, Benue, Cross River, Ebonyi, Gombe, Kano, and Kwara, as well as the Federal Capital Territory (FCT).

According to health authorities, demand for the injection has been rising since its introduction, with officials attributing part of the decline in reported cases to improved prevention coverage.

Nigeria received its first shipment of the drug on March 10, 2026, with over 52,000 doses secured for the rollout. So far, 11,520 doses have been distributed nationwide.

The Federal Ministry of Health and Social Welfare described the development as a major milestone in Nigeria’s effort to eliminate HIV as a public health threat.

The National AIDS, Viral Hepatitis and STIs Control Programme said the injectable offers sustained protection and improves adherence to prevention among people at risk.